Celgene BMS IM047-029

Have you been diagnosed with Ulcerative Colitis? If so, we are looking for participants over the age of 18 who are diagnosed with Ulcerative colitis to take part in a research study for an investigational drug for UC symptoms. You may qualify to take part in this study if you have been diagnosed with UC for at 3 months.

There is no cost to take part in this study. The study drug and all related study tests that aren’t part of your normal care will be provided at no cost. You may be reimbursed for study-related expenses, such as travel and parking fees

Location: MNGI Digestive Health, Plymouth Clinic

Physician Investigator:  Dr. McCabe

Study Coordinator: Chisom Ogbu

 

ExiGem

The ExiGem Study is now enrolling.

Ulcerative colitis is a chronic, relapsing, inflammatory disorder of the gastrointestinal (GI) tract characterized by inflammation and ulcers limited to the colon. If you have been diagnosed with moderate to severely active ulcerative colitis, you may be eligible to participate in a clinical study evaluating an investigational treatment.

To see if the ExiGem Study is right for you, please contact us below.

Location: MNGI Digestive Health, Plymouth Clinic

Physician Investigator: Dr. Campbell

Study Coordinator: Tyler Pham

ATTENTION: This form is for information only and does not guarantee participation in any study. This form is also not meant for transmitting medical, prescription or appointment information or to initiate direct communications with our health care providers. Those inquiries should be sent through the Patient Portal or you can contact us at (612) 871-1145. Web form submissions are monitored Monday through Friday during regular business hours. In the event of a medical emergency, please dial 911.

CAPTCHA
2 + 8 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.